ATTOVIA THERAPEUTICS, INC.

Consensus Attovia Therapeutics, Inc.

Stocks

ATTO

US04987L1026

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-11 EDT			5-day change	1st Jan Change
22.79 ^USD	+1.15%		-10.80%	-

09-02	Attovia Therapeutics Q2 Net Loss Widens	MT
09-02	Attovia Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Evolution of the Average Target: Attovia Therapeutics, Inc.

Evolution of the Target Price: Attovia Therapeutics, Inc.

Changes in Analyst Recommendations: Attovia Therapeutics, Inc.

f583a214dd0a07546.cOSMKup3q40qv4vQFcVhjwKl4TrHvkUF--Gyp_q_8ZQ.RdTOW7ky_7l1092nJ7E4okzmiHC90DNJv9n13qLOnc0fiOhnqw3IwRPUzg~033db840e11a7f187328484d3c102f79

Analysts' recommendations: Attovia Therapeutics, Inc.

08-31	Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says	MT
08-31	Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating	MT
08-31	Leerink Partners Initiates Attovia Therapeutics at Outperform With $52 Price Target	MT
08-31	RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target	MT
08-31	Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target	MT

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ATTOVIA THERAPEUTICS, INC.	-	-			+87.31%
	WUXI APPTEC CO., LTD.					+21.08%
	ARGENX SE					+17.64%
	INSMED INCORPORATED					+57.28%
	WUXI BIOLOGICS (CAYMAN) INC.					+22.33%
	BIONTECH SE					+23.63%
	GENMAB A/S					+17.8%
	PHARMAESSENTIA CORPORATION					+5.85%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+30.36%
	EXELIXIS, INC.					-6.52%
	Average					+27.68%
	Weighted average by Cap.					+22.42%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

22.79USD

Average target price

42.20USD

Spread / Average Target

+85.17%

High Price Target

52.00USD

Spread / Highest target

+128.17%

Low Price Target

30.00USD

Spread / Lowest Target

+31.64%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
ATTO Stock
Consensus Attovia Therapeutics, Inc.

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!